12 Best Penny Stocks to Invest in According to the Media
On December 24, Global Advisors’ managing partner, Tom Lee, shared his thoughts on the potential of small and mid-cap stocks in 2025.
Applied Therapeutics Inc. (APLT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vestal Point Capital Ryan Wilder | 11,500,000 | $9,846,300 | +905% | 0.58% |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 9,615,420 | $8,232,723 | +47% | 8.17% |
| 3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 8,762,291 | $7,502,272 | +2459% | 0.04% |
| 4. | Knoll Capital Management Fred Knoll | 5,799,687 | $4,964,532 | +5% | 3.19% |
| 5. | Alyeska Investment Group Anand Parekh | 2,707,497 | $2,318,159 | +176% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.18 | 30,000 | Director | 63,000 | 2023-12-01 | Filing | |
| $0.65 | 50,000 | Large Shareholder, Officer, Director | 767,495 | 2022-10-14 | Filing | |
| $0.56 | 73,256 | Large Shareholder, Officer, Director | 717,495 | 2022-10-13 | Filing | |
| $0.52 | 38,153 | Large Shareholder, Officer, Director | 644,239 | 2022-10-12 | Filing | |
| $1.00 | 2,065,000 | Large Shareholder | 4,555,077 | 2022-06-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.61 | 22,950 | 404,961 | 2025-02-06 | Filing | ||
| $0.61 | 86,078 | 900,775 | 2025-02-06 | Filing | ||
| $0.61 | 28,117 | 271,883 | 2025-02-06 | Filing | ||
| $5.83 | 13,530 | 277,911 | 2024-08-22 | Filing | ||
| $5.83 | 22,681 | 986,853 | 2024-08-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,990,591 | $8,553,944 | 0.58% | |
| 2. | 9,296,075 | $7,959,300 | 0% | |
| 3. | 8,815,780 | $7,548,070 | 0% | |
| 4. | 5,548,231 | $4,749,286 | 0% | |
| 5. | 4,468,122 | $3,842,584 | 0% |
News See All
10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
5 Hot Penny Stock On the Move
Applied Therapeutics Inc (NASDAQ:APLT) shares jumped about 79% over the past five days through February 22.
13 Best Booming Stocks to Buy Right Now
Despite latest data showing elevated inflation and a decline in retail sales, some major investment firms are looking beyond the short-term market turbulence and issuing highly positive outlook for the...
12 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023.
10 Stocks That Will Go Up 1000 Percent
There are only two ways to make money by investing in the stock market. The first is being extremely lucky and getting rich fast via speculative stocks.
Hedge Fund and Insider Trading News: Crispin Odey, Bill Ackman, Point72 Asset Management, Elliott Management, Charles River Laboratories International Inc (CRL), Corvus Gold Inc (KOR), and More
Crispin Odey’s long decline is exposing a new risk for the investors who are left: as his troubled money pool gets smaller, a larger slice is in hard-to-sell holdings.
Is APLT A Good Stock To Buy Now?
In this article we will take a look at whether hedge funds think Applied Therapeutics, Inc. (NASDAQ:APLT) is a good investment right now.
Is Applied Therapeutics (APLT) a Smart Long-term Buy?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Billionaire Hedge Funds
